BioSpace News Archive

Business

Vilacto Bio Inc. Retains Established Independent Investor Relations Firm, The Equity Group Inc.

Vilacto Bio selected The Equity Group due to its 43-year track record of delivering specialized, comprehensive IR programs for small- and mid-sized public companies.

November 17, 2017

·

2 min read

Policy

Helius Medical Technologies Provides Clarification on Clinical Trial Results and Confirms Intention to Include Traumatic Brain Injury (TBI) Registrational and Long-Term Treatment Trial Data to Support Application for Clearance by the FDA

The company wishes to clarify the observations from the two trials previously reported and its plans to include the data in an application for marketing authorization by FDA.

November 17, 2017

·

11 min read

Neovasc Closes Offering of Units Consisting of Common Shares and Warrants and Concurrent Private Placement of Notes and Warrants

The Company intends to use the net proceeds from the Offering and Concurrent Private Placement to fully fund the approximately US$42M balance of the damages and interest awards granted in the litigation with CardiAQ.

November 17, 2017

·

7 min read

Genetown

EightSpokes Release: New Peer-to-Peer Feedback Drives Employee Engagement to Improve Work Quality

EightSpokes introduces P2P Feedback with its latest release of Enlighten, the world’s first cloud-based EPC solution.

November 17, 2017

·

4 min read

Business

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

Sales for the third quarter of 2017 increased 39% compared to the third quarter of 2016

November 17, 2017

·

18 min read

Philips Wins FDA Nod for Small Parts Ultrasound Tr

Policy

Arbutus’ LNP Licensee Alnylam Initiates Rolling Submission of NDA to U.S. FDA for Patisiran

This submission allows the FDA to review completed portions of the NDA on an ongoing basis. Alnylam expects to submit final clinical data by year end.

November 17, 2017

·

3 min read

Drug Development

Agios Presents Updated Phase I Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients With IDH1 Mutant Positive Glioma

The data were presented today in an oral presentation at the Society for Neuro-Oncology Annual Meeting in San Francisco.

November 17, 2017

·

9 min read

Intrexon Enters Into $100M Preferred Stock Equity

Deals

scPharmaceuticals Nabs $89.6M in IPO

The company’s common stock will begin trading on the Nasdaq under the ticker symbol “SCPH” today.

November 17, 2017

·

2 min read

Business

Precipio to Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time

Management will host a conference call on Tuesday, November 21, 2017 at 9:00am to review financial results and provide a corporate update.

November 17, 2017

·

2 min read

Drug Development

Celldex Therapeutics Initiates Phase II Combination Study of CDX-3379 and Cetuximab in Head and Neck Squamous Cell Carcinoma

The study will enroll approximately 30 patients with cetuximab-resistant, advanced HNSCC who have previously been treated with an anti-PD1 checkpoint inhibitor.

November 17, 2017

·

6 min read